Find out how Toxicology in the 21st Century researchers have developed faster, cheaper and more effective testing methods to analyze the effects of chemicals on human health.
NCATS chemical screening resources enable studies on potential treatments for Parkinson's and related diseases.
NCATS researchers provided crucial pre-clinical resources for Aes-103, a potential therapeutic to treat sickle cell disease.
NCATS scientists exploring the lipoxygenase enzyme family have enabled development of three chemical probes with the potential to treat diabetes, stroke and thrombosis.
How is NCATS advancing translational research? Learn more about the Center's work and some of its early successes.
MORE CENTER NEWS
NIH launches program to explore poorly understood genes.
- Test Reliably Detects Inherited Immune Deficiency in Newborns • NIAID, NICHD
- Antibacterial Soap Exposes Health Workers to High Triclosan Levels • University of California San Francisco
- Building a Bridge • Drug Discovery News
- More News & Events...